Literature DB >> 20495838

Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ/PI3-K/Akt signaling pathways.

Rong-Rong Cui1, Ding-An Mao, Lu Yi, Cheng Wang, Xing-Xing Zhang, Hui Xie, Xian-Ping Wu, Xiao-Bo Liao, Hua Zhou, Ji-Cai Meng, Ling-Qing Yuan, Er-Yuan Liao.   

Abstract

Apoptosis of vascular smooth muscle cells (VSMCs) plays an important role in regulating vascular remodeling during cardiovascular diseases. Apelin is the endogenous ligand for the G-protein-coupled receptor APJ and plays an important role in the cardiovascular system. However, the mechanisms of apelin on apoptosis of VSMCs have not been elucidated. Using a culture of human VSMCs as a model for the study of apoptosis, the relationship between apelin and apoptosis of human VSMCs and the signal pathway involved were investigated. Using western blotting, we confirmed that VSMCs could express APJ. To evaluate the possible role of apelin in VSMC apoptosis, we assessed its effect on apoptosis of human VSMCs. The results showed that apelin inhibited human VSMCs apoptosis induced by serum deprivation. Suppression of APJ with small-interfering RNA (siRNA) abolished the anti-apoptotic activity of apelin. Apelin increased Bcl-2 protein expression, but decreased Bax protein expression. An increase in activation of extracellular signal-regulated protein kinase (ERK) and Akt (a downstream effector of phosphatidylinositol 3-kinase) was shown after apelin stimulation. Suppression of APJ with siRNA abolished the apelin-induced activation of ERK and Akt. LY294002 (a PI3-K inhibitor) blocked apelin-induced activation of Akt and abolished the apelin-induced antiapoptotic activity. Our study suggests that apelin suppresses serum deprivation-induced apoptosis of human VSMCs, and that the anti-apoptotic action is mediated through the APJ/PI3-K/Akt signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20495838     DOI: 10.1007/s00726-010-0555-x

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  25 in total

Review 1.  Vascular effects of apelin: Mechanisms and therapeutic potential.

Authors:  Amreen Mughal; Stephen T O'Rourke
Journal:  Pharmacol Ther       Date:  2018-05-25       Impact factor: 12.310

Review 2.  Apelinergic System Structure and Function.

Authors:  Kyungsoo Shin; Calem Kenward; Jan K Rainey
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

3.  Apelin-13 protects the brain against ischemic reperfusion injury and cerebral edema in a transient model of focal cerebral ischemia.

Authors:  Mehdi Khaksari; Nahid Aboutaleb; Farinaz Nasirinezhad; Abedin Vakili; Zahra Madjd
Journal:  J Mol Neurosci       Date:  2012-05-26       Impact factor: 3.444

Review 4.  Effects of apelin on the cardiovascular system.

Authors:  Anna Folino; Pier Giorgio Montarolo; Michele Samaja; Raffaella Rastaldo
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

5.  Evaluation of Apelin/APJ system expression in hepatocellular carcinoma as a function of clinical severity.

Authors:  Manuela Cabiati; Melania Gaggini; Paolo De Simone; Silvia Del Ry
Journal:  Clin Exp Med       Date:  2020-11-17       Impact factor: 3.984

6.  Apelin-13 infusion salvages the peri-infarct region to preserve cardiac function after severe myocardial injury.

Authors:  Wook-Jin Chung; Ahryon Cho; Kyunghee Byun; Jeongsik Moon; Xiaohu Ge; Hye-Sun Seo; Ejung Moon; Rajesh Dash; Phillip C Yang
Journal:  Int J Cardiol       Date:  2016-08-02       Impact factor: 4.164

Review 7.  The biological function of ELABELA and APJ signaling in the cardiovascular system and pre-eclampsia.

Authors:  Yuanyuan Liu; Liquan Wang; Hongjun Shi
Journal:  Hypertens Res       Date:  2019-01-09       Impact factor: 3.872

8.  Apelin attenuates the osteoblastic differentiation of vascular smooth muscle cells.

Authors:  Peng-Fei Shan; Ying Lu; Rong-Rong Cui; Yi Jiang; Ling-Qing Yuan; Er-Yuan Liao
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

9.  Apelin and pulmonary hypertension.

Authors:  Charlotte U Andersen; Ole Hilberg; Søren Mellemkjær; Jens E Nielsen-Kudsk; U Simonsen
Journal:  Pulm Circ       Date:  2011 Jul-Sep       Impact factor: 3.017

10.  Puerarin Suppress Apoptosis of Human Osteoblasts via ERK Signaling Pathway.

Authors:  Ling-Juan Liu; Li-Qun Liu; Tao Bo; Shi-Jun Li; Zhen Zhu; Rong-Rong Cui; Ding-An Mao
Journal:  Int J Endocrinol       Date:  2013-06-12       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.